May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Retinal Safety Study of Intravitreal Genistein in a Rabbit Model
Author Affiliations & Notes
  • T. Fiore
    Ophthalmology, Eye Clinic, University of Perugia, Perugia, Italy
  • B. Iaccheri
    Ophthalmology, Eye Clinic, University of Perugia, Perugia, Italy
  • F. Pietrolucci
    Ophthalmology, Eye Clinic, University of Perugia, Perugia, Italy
  • C. Cagini
    Ophthalmology, Eye Clinic, University of Perugia, Perugia, Italy
  • F. Florio
    Ophthalmology, Eye Clinic, University of Perugia, Perugia, Italy
  • F. Giansanti
    Ophthalmology, University of Florence, Florence, Italy
  • A. Cavaliere
    Institute of Pathological Anatomy and Histology Perugia, University, Italy., Perugia, Italy
  • R. Colella
    3Institute of Pathological Anatomy and Histology, Perugia, University, Italy., Perugia, Italy
  • M. Mameli
    Ophthalmology,
    3Institute of Pathological Anatomy and Histology, Perugia, University, Italy., Perugia, Italy
  • Footnotes
    Commercial Relationships  T. Fiore, None; B. Iaccheri, None; F. Pietrolucci, None; C. Cagini, None; F. Florio, None; F. Giansanti, None; A. Cavaliere, None; R. Colella, None; M. Mameli, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5607. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Fiore, B. Iaccheri, F. Pietrolucci, C. Cagini, F. Florio, F. Giansanti, A. Cavaliere, R. Colella, M. Mameli; Retinal Safety Study of Intravitreal Genistein in a Rabbit Model. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5607. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the preclinical safety of intravitreal genistein in rabbit eyes over a short-term period.

Methods: : Twelve New Zealand albino rabbits were selected for this study. Four concentrations of genistein were prepared: 24 mg/0.1 mL, 135 mg/0.1 mL, 270 mg/0.1 mL and 540 mg/0.1 mL. Each concentration was injected intravitreally in one eye of three rabbits. As a control, the vehicle solution was injected into the other eye of each animal. Retinal safety of intravitreal genistein was studied with electroretinography (ERG) and histopathology in rabbits. ERG recordings were made before the injection and 3 weeks after. Eventually, the rabbits were euthanatized and the retinas examined by light and electron microscopy. Immunohistochemical staining with caspase-3 and -9 was also performed to evaluate apoptotic expression in all study and control sections.

Results: : ERG studies showed no significant difference between control and genistein-injected eyes at any of the doses in the rabbit model. Histological examination revealed no retinal abnormality in the rabbits injected with each concentration of genistein. Immunohistochemical staining with caspase-3 and -9 showed no different apoptotic protein expression in all study and control sections.

Conclusions: : Our results indicate that genistein is a safe intravitreal drug in the rabbit model up to 540 mg. If proven safe and efficacious in further studies, intravitreal injection of genistein could be considered an alternative therapy to that currently used in selected patients.

Keywords: injection • drug toxicity/drug effects • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×